These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36707842)

  • 21. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Res Ther; 2013; 15(3):R63. PubMed ID: 23718566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.
    Yalçınkaya Y; Adın-Çınar S; Artim-Esen B; Kamalı S; Pehlivan Ö; Öcal L; Deniz G; Inanç M
    Microvasc Res; 2016 Nov; 108():17-21. PubMed ID: 27392528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.
    van den Hombergh WMT; Kersten BE; Knaapen-Hans HKA; Thurlings RM; van der Kraan PM; van den Hoogen FHJ; Fransen J; Vonk MC
    Trials; 2018 Aug; 19(1):449. PubMed ID: 30134971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
    Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.
    Lambova S; Hermann W; Muller-Ladner U
    Curr Rheumatol Rev; 2013; 9(4):254-60. PubMed ID: 26932290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review.
    Paxton D; Pauling JD
    Semin Arthritis Rheum; 2018 Dec; 48(3):482-494. PubMed ID: 29602558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis.
    Piera-Velazquez S; Dillon ST; Gu X; Libermann TA; Jimenez SA
    PLoS One; 2022; 17(12):e0279461. PubMed ID: 36548367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma.
    Araújo FC; Camargo CZ; Kayser C
    Rheumatol Int; 2017 Nov; 37(11):1825-1833. PubMed ID: 28819792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis.
    Avouac J; Lepri G; Smith V; Toniolo E; Hurabielle C; Vallet A; Amrouche F; Kahan A; Cutolo M; Allanore Y
    Semin Arthritis Rheum; 2017 Aug; 47(1):86-94. PubMed ID: 28291582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.
    Liem SIE; Neppelenbroek S; Fehres CM; Wevers BA; Toes REM; Allaart CF; Huizinga TWJ; Scherer HU; De Vries-Bouwstra JK
    RMD Open; 2023 Feb; 9(1):. PubMed ID: 36746531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.
    Andrigueti FV; Arismendi MI; Ebbing PC; Kayser C
    Microvasc Res; 2015 Mar; 98():82-7. PubMed ID: 25596148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oesophageal manometry in early and definite systemic sclerosis.
    Airò P; Della Casa D; Danieli E; Missale G; Cattaneo R; Cestari R
    Clin Rheumatol; 2005 Aug; 24(4):370-6. PubMed ID: 15592901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
    Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L
    Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
    Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
    Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
    Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
    Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice.
    Jordan S; Maurer B; Toniolo M; Michel B; Distler O
    Rheumatology (Oxford); 2015 Aug; 54(8):1454-8. PubMed ID: 25762528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.